Interpace Diagnostics Reports First Quarter 2019 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Interpace Diagnostics (IDXG) Misses Q1 EPS by 4c, Revenues Miss; Offers FY19 Revenue Outlook
May 13, 2019 4:12 PM EDTInterpace Diagnostics (NASDAQ: IDXG) reported Q1 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $6.01 million versus the consensus estimate of $6.33 million.
FIRST QUARTER 2019 FINANCIAL PERFORMANCE
Net Revenue was $6.01 million, an increase of 25% over the first quarter of 2018;Gross Profit was 56%, an improvement compared to 46% in the first quarter of 2018;Sales & marketing Expenses, were $2.4 million or 40% of Net Revenues an improvement as... More